期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Clinical benefits of rational-emotive stress management therapy for job burnout and dysfunctional distress of special education teachers 被引量:1
1
作者 Liziana N Onuigbo Charity N Onyishi Chiedu Eseadi 《World Journal of Clinical Cases》 SCIE 2020年第12期2438-2447,共10页
It has been observed that managing job burnout and dysfunctional distress constitute part of the major challenges among special educators,and that empirical data on the management of burnout and dysfunctional distress... It has been observed that managing job burnout and dysfunctional distress constitute part of the major challenges among special educators,and that empirical data on the management of burnout and dysfunctional distress associated with the job of special education teachers are lacking in the literature.The current article discusses the clinical benefits of a rational-emotive stressmanagement therapy program in reducing the level of job burnout symptoms and dysfunctional distress in special education teachers,using evidence from a 2018 clinical trial study that reported the efficacy of this intervention.Results show the clinical benefits and implications of conducting a rational-emotive stress management intervention,and recommendations are made for future research. 展开更多
关键词 clinical benefits Dysfunctional distress Job burnout Rational-emotive behavior therapy Rational-emotive stress management therapy Special education teachers
下载PDF
Clinical Benefits as Endpoints in Advanced Non-Small Cell Lung Cancer Treated with Integrative Medicine 被引量:3
2
作者 薛冬 李萍萍 《Chinese Journal of Integrative Medicine》 SCIE CAS 2011年第2期228-231,共4页
"Living with cancer" and symptom control are the features and advantages of integrative medicine in advanced non-small cell lung cancer (NSCLC) treatment. However, with the current concept of response evaluation c... "Living with cancer" and symptom control are the features and advantages of integrative medicine in advanced non-small cell lung cancer (NSCLC) treatment. However, with the current concept of response evaluation criteria by the WHO and RECIST, it is difficult to exhibit the above characteristics. Clinical benefit (CB) is designed as an endpoint recently widely understood and accepted in oncology clinical trials. With the review of its definition and development, we suggest CB to be used as an endpoint in advanced NSCLC treatment with integrative medicine. CB should encompass two connotations: one is improved quality of life and symptom control and the other is disease control rate (DCR), including complete response (CR), partial response (PR), and stable disease (SD). We need to design randomized controlled trials (RCT) to investigate the interrelationship of CB rate and survival to provide high-grade evidence proving that advanced lung cancer patients could really benefit from integrative medicine treatment. 展开更多
关键词 non-small cell lung cancer Chinese medicine ENDPOINTS clinical benefit
原文传递
Could We Use Clinical Benefit to Evaluate the Effects of Chinese Medicine on the Treatment of Cancer? 被引量:3
3
作者 李萍萍 《Chinese Journal of Integrative Medicine》 SCIE CAS 2010年第1期9-10,共2页
The patients, who cannot endure the chemotherapy anymore, or internal disease or present drug resistance, normally use CM for improving their physical conditions and inhibiting tumor. CM has got excellent reputation b... The patients, who cannot endure the chemotherapy anymore, or internal disease or present drug resistance, normally use CM for improving their physical conditions and inhibiting tumor. CM has got excellent reputation because of the effects. Nonetheless, few clinical articles of CM to treat cancer are published on major international journals up to now. 展开更多
关键词 Could We Use clinical Benefit to Evaluate the Effects of Chinese Medicine on the Treatment of Cancer WE QOL
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部